The development of the PROMPT (Prescribing Optimally in Middle-aged People's Treatments) criteria

BMC Health Services Research

Volumn 14, Issue 1, 2014, Pages

  Cooper, Janine A ^a,b   Ryan, Cristín ^a   Smith, Susan M ^b   Wallace, Emma ^b   Bennett, Kathleen ^c   Cahir, Caitriona ^c   Williams, David ^b   Teeling, Mary ^c   Fahey, Tom ^b   Hughes, Carmel M ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Delphi technique; Explicit criteria; Middle age; Multimorbidity; Polypharmacy; Potentially inappropriate prescribing

Indexed keywords

DELPHI STUDY; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; POLYPHARMACY; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PROGRAM DEVELOPMENT; QUESTIONNAIRE;

DELPHI TECHNIQUE; FEMALE; GUIDELINES AS TOPIC; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; POLYPHARMACY; PROGRAM DEVELOPMENT; QUESTIONNAIRES;

EID: 84921819226     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-014-0484-6     Document Type: Article

References (26)

1. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC: Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012, 5:CD008165.
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012, 380:37-43. 9.
3. Hughes LD, McMurdo ME, Guthrie B: Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing 2013, 42(1):62-69.
4. Gallagher P, Barry P, O'Mahony D: Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007, 32(2):113-121.
5. Kaufmann CP, Tremp R, Hersberger KE, Lampert ML: Inappropriate prescribing: a systematic overview of published assessment tools. Eur J ClinPharmacol 2013, 70(1):1-11.
6. Mangoni AA, Jackson SHD: Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004, 57(1):6-14.
7. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT: Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007, 370:173-184.
8. O'Connor MN, Gallagher P, O'Mahony D: Inappropriate prescribing: criteria, detection and prevention. Drugs Aging 2012, 29:437-452.
9. American Geriatrics Society 2012: Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012, 60:616-631.
10. Holt S, Schmiedl S, Thurmann PA: Potentially inappropriate medications for the elderly: the PRISCUS list. Dtsch ArztblInt 2010, 107(31-32):543-551.
11. Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J: The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 2009, 27:153-159.
12. Basger BJ, Chen TF, Moles RJ: Inappropriate medication use and prescribing indicators in elderly Australians. Drugs Aging 2008, 25(9):777-793.
13. Winit-Watjana W, Sakulrat P, Kespichayawattana J: Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr 2008, 47:35-51.
14. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D: STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008, 46:72-83.
15. Laroche ML, Charmes JP, Merle L: Potentially inappropriate medications in the elderly: a French consensus panle list. Eur J Clin Pharmacol 2007, 63:725-731.
16. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997, 156(3):385-391.
17. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K: Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 2010, 69(5):543-552.
18. Bradley MC, Fahey T, Cahir C, Bennett K, O'Reilly D, Parsons C, Hughes CM: Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 2012, 68(10):1425-1433.
19. Campbell SM, Cantrill JA: Consensus methods in prescribing research. J Clin Pharm Ther 2001, 26(1):5-14.
20. Jamieson S: Likert scales: how to (ab)use them. Med Educ 2004, 38:1217-1218.
21. MHRA Drug Safety Update 2010. Medicines and Healthcare products Regulatory Agency: Clopidogrel and proton pump inhibitors: interaction-updated advice. [http://www.mhra.gov.uk/Safetyinformation/ DrugSafetyUpdate/CON087711]
22. BNF Joint Formulary Committee: British National Formulary. 65th edition. London: BMJ Group and Pharmaceutical Press; 2013.
23. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA: Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract 2011, 61(582):12-21.
24. Marriott J, Stehlik P: A critical analysis of the methods used to develop explicit clinical criteria for use in older people. Age Ageing 2012, 41:441-450.
25. Brilleman SL, Purdy S, Salisbury C, Windmeijer F, Gravelle H, Hollinghurst S: Implications of comorbidity for primary care costs in the UK: a retrospective observational study. Br J Gen Pract 2013, 69(609):274-282.
26. McDaid O, Hanly MJ, Richardson K, Kee F, Kenny RA, Savva GM: The effect of multiple chronic conditions on self-rated health, disability and quality of life among the older populations of Northern Ireland and the Republic of Ireland: a comparison of two nationally representative cross-sectional surveys. BMJ Open 2013, 3(6):e002571.